Valuation: Avantor, Inc.

Market Cap 10.31B 9.1B 8.61B 7.81B 14.63B 989B 14.78B 103B 39.79B 505B 38.71B 37.86B 1,625B P/E 2026 *
45.6x
P/E 2027 * 32.7x
Enterprise Value 13.37B 11.8B 11.16B 10.13B 18.98B 1,283B 19.17B 134B 51.62B 655B 50.21B 49.12B 2,108B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.89x
Free-Float
95.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 57 2026-09-20
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 69 2025-12-31
Director/Board Member 62 2021-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 10.31B
-0.03%-2.64%-24.16%+4.23% 175B
-2.69%-4.05%-7.32%+11.14% 111B
+1.25%-2.17%-0.15%+70.92% 58.7B
+1.53%+1.90%+15.16%+55.54% 49.27B
-1.01%-0.56%-1.10%-29.61% 49.57B
-0.05%-3.23%+30.36%-7.14% 32.69B
-0.26%+1.60% - - 30.69B
+0.26%+1.49%+44.68%+0.38% 26.51B
-0.18%+5.45%+26.01%-3.39% 23.95B
Average +0.18%+0.08%+10.44%+12.76% 61.94B
Weighted average by Cap. -0.01%-1.37%-2.95%+13.49%

Financials

2026 *2027 *
Net sales 6.59B 5.82B 5.5B 4.99B 9.36B 633B 9.45B 66.04B 25.45B 323B 24.76B 24.22B 1,040B 6.74B 5.95B 5.63B 5.11B 9.57B 647B 9.67B 67.55B 26.03B 330B 25.32B 24.77B 1,063B
Net income 225M 199M 188M 170M 320M 21.6B 323M 2.26B 869M 11.03B 845M 827M 35.5B 311M 274M 259M 235M 441M 29.82B 446M 3.11B 1.2B 15.23B 1.17B 1.14B 49B
Net Debt 3.06B 2.7B 2.56B 2.32B 4.35B 294B 4.39B 30.68B 11.83B 150B 11.5B 11.25B 483B 2.42B 2.14B 2.02B 1.83B 3.44B 232B 3.47B 24.27B 9.35B 119B 9.1B 8.9B 382B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-